Literature DB >> 16496103

[Cardiogenic shock after acute myocardial infarction].

U Janssens1.   

Abstract

Cardiogenic shock remains the major cause of death among patients with acute myocardial infarction. Besides supportive therapy there is clear evidence that revascularization of the infarct related artery should be performed as soon as possible with percutaneous transluminal coronary angioplasty. Placement of coronary stents and administration of platelet glycoprotein IIb/IIIa antagonists may further improve outcome. Intra-aortic balloon pumping should be integral part of this treatment strategy but is unfortunately underused in clinical practice. Routine bypass surgery for cardiogenic shock patients is deferred and restricted to selected patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496103     DOI: 10.1007/s00108-006-1586-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

Review 1.  Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.

Authors:  Judith S Hochman
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Anvar Babaev; Paul D Frederick; David J Pasta; Nathan Every; Tina Sichrovsky; Judith S Hochman
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

3.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

4.  Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock.

Authors:  Satyendra Giri; Joseph Mitchel; Rabih R Azar; Francis J Kiernan; Daniel B Fram; Raymond G McKay; Roger Mennett; Jonathan Clive; Jeffrey A Hirst
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

5.  The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

Authors:  V Menon; H White; T LeJemtel; J G Webb; L A Sleeper; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.

Authors:  Gad Cotter; Edo Kaluski; Olga Milo; Alex Blatt; Ahmed Salah; Alberto Hendler; Rikardo Krakover; Ahuva Golick; Zvi Vered
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

9.  Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.

Authors:  G Delle Karth; A Buberl; A Geppert; T Neunteufl; M Huelsmann; C Kopp; M Nikfardjam; R Berger; G Heinz
Journal:  Acta Anaesthesiol Scand       Date:  2003-11       Impact factor: 2.105

Review 10.  [Levosimendan in cardiology and intensive care medicine].

Authors:  Georg Delle Karth; Gottfried Heinz
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.